| GENERIC NAME | Cinacalcet.HCl Tablets |
| STRUCTURE | ((R)-N-(3-(3-(trifluoromethoxy)phenyl)proyl)-1-(1-naphthyl)ethylamine |
| INDICATION'S |
APPROVED INDICATIONS - Sec. HyperParaThyroidism>End Stage Re nal Disease - Sec. HyperParaThyroidism>CKD Dialysis NON-APPROVED INDICATIONS - Primary HyperParaThyroidism (Ph. II) - Sec. HyperParaThyroidism>CKD>Stages 3 & 4) (Ph. III) |
| MARKETER'S COUNTRY | USA |
| UPDATE | 01.26.06 |
| COMPANY | This data is not available for free |
| LICENSEE | Co. |
| LICENSOR | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |